CLOV vs CORT
Clover Health Investments Corp (CLOV) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
CLOV currently screens at market cap $1.55B. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the CLOV and CORT stock pages for the full models.
Not investment advice.